Evidence map›Paper›PMID 19029404›Full record

ArticleThe journal of histochemistry and cytochemistry : official journal of the Histochemistry Society2009

Enhanced angiogenesis and reduced contraction in thrombospondin-2-null wounds is associated with increased levels of matrix metalloproteinases-2 and -9, and soluble VEGF.

Susan Maclauchlan, Eleni A Skokos, Azin Agah, Jianmin Zeng, Weiming Tian, Jeffrey M Davidson, Paul Bornstein, Themis R Kyriakides

Open access · bronzeAbstract read
In one paragraph

Article in The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
5.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Targeting hypoxia and thrombospondin-2 in diabetic wound healing.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. HIF-1α represses the expression of the angiogenesis inhibitor thrombospondin-2.Matrix biology : journal of the International Society for Matrix Biology · 2018
    Article
  13. Article
  14. Thrombospondins: A Role in Cardiovascular Disease.International journal of molecular sciences · 2017
    Review
  15. Intraluminal delivery of thrombospondin-2 small interfering RNA inhibits the vascular response to injury in a rat carotid balloon angioplasty model.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2017
    Article
  16. Thrombospondins in the transition from myocardial infarction to heart failure.Journal of molecular and cellular cardiology · 2016
    Review
  17. Article
  18. Integrins in Wound Healing.Advances in wound care · 2014
    Review
  19. Thrombospondin-2 and extracellular matrix assembly.Biochimica et biophysica acta · 2014
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Susan MaclauchlanInterdepartmental Program in Vascular Biology and Therapeutics and Departments of Pathology and Biomedical Engineering, Yale University, New Haven, Connecticut, USA.
Eleni A Skokos
Azin Agah
Jianmin Zeng
Weiming Tian
Jeffrey M Davidson
Paul Bornstein
Themis R Kyriakides
Yale University · USUniversity of South Alabama · USUniversity of Washington · USVanderbilt University · US

Funding

MCP-1 and attenuation of the foreign body responseR01GM072194 · NIGMS · YALE UNIVERSITY · PI KYRIAKIDES, THEMIS R · 2005 to 2018
$4.7M
ELASTIN AND COLLAGEN IN THE AGING PROCESSR01AG006528 · NIA · VANDERBILT UNIVERSITY · PI DAVIDSON, JEFFREY M. · 1986 to 2011
$2.9M
EXTRACELLULAR MATRIX IN MICE LACKING THROMBOSPONDIN 2R01AR045418 · NIAMS · UNIVERSITY OF WASHINGTON · PI BORNSTEIN, PAUL · 1998 to 2006
$2.1M
NIAMS NIH HHS AR-45418NIAMS NIH HHS R01 AR045418NIA NIH HHS AG-06528NIA NIH HHS R01 AG006528NIGMS NIH HHS GM-072194-01NIGMS NIH HHS R01 GM072194
6 · The paper itself

Abstract

Thrombospondin-2 (TSP2) is an inhibitor of angiogenesis with pro-apoptotic and anti-proliferative effects on endothelial cells. Mice deficient in this matricellular protein display improved recovery from ischemia and accelerated wound healing associated with alterations in angiogenesis and extracellular matrix remodeling. In this study, we probed the function of TSP2 by performing a detailed analysis of dermal wounds and wound-derived fibroblasts. Specifically, we analyzed incisional wounds by tensiometry and found no differences in strength recovery between wild-type and TSP2-null mice. In addition, analysis of full-thickness excisional wounds by terminal deoxynucleotidyl transferase-mediated 2'-deoxyuridine 5'-triphosphate nick-end labeling stain and MIB-5 immunohistochemistry revealed similar numbers of apoptotic and proliferating cells, respectively. In contrast, the levels of matrix metalloproteinase (MMP)-2, MMP-9, tissue inhibitors of metalloproteinase (TIMP)-1, TIMP-2, and soluble vascular endothelial growth factor were increased in wounds of TSP2-null mice. Evaluation of the ability of TSP2-null wound fibroblasts to contract collagen gels revealed that it was compromised, even though TSP2-null wounds displayed normal myofibroblast content. Therefore, we conclude that the lack of TSP2 leads to aberrant extracellular matrix remodeling, increased neovascularization, and reduced contraction due in part to elevated levels of MMP-2 and MMP-9. These observations provide in vivo supporting evidence for a newly proposed function of TSP2 as a modulator of extracellular matrix remodeling.

Indexed as

Neovascularization, PhysiologicWound HealingAnimalsApoptosisCell DifferentiationCell ProliferationCollagenExtracellular MatrixFibroblastsGelsMatrix Metalloproteinase 2Matrix Metalloproteinase 9MiceMice, KnockoutMuscle, SmoothSkinCollagenGelsMatrix Metalloproteinase 2Matrix Metalloproteinase 9Thrombospondin 2ThrombospondinsVascular Endothelial Growth Factor Avascular endothelial growth factor A, mouse

Identifiers

PMID19029404
PMCPMC2664984
OpenAlexW2023338824

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.